Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, ebrary, Inc, & Wizemann, T. (2010). Public health effectiveness of the FDA 510(k) clearance process: Balancing patient safety and innovation : workshop report. National Academies Press.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Inc ebrary, and Theresa Wizemann. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. Washington, D.C.: National Academies Press, 2010.
Successfully copied to clipboard
Copying to clipboard failed
MLA引文
Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, et al. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. National Academies Press, 2010.
Successfully copied to clipboard
Copying to clipboard failed
警告:這些引文格式不一定是100%准確.